TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Consun Pharmaceutical Group Ltd. ( (HK:1681) ) has provided an update.
Consun Pharmaceutical Group Ltd. has scheduled a board meeting for August 19, 2025, to discuss and approve the unaudited consolidated interim results for the first half of the year, consider the announcement of these results, and deliberate on the potential payment of an interim dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial health and strategic decisions, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Consun Pharmaceutical Group Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on the production and distribution of pharmaceutical products, with its shares listed on the Hong Kong Stock Exchange.
Average Trading Volume: 2,553,556
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.23B
For detailed information about 1681 stock, go to TipRanks’ Stock Analysis page.